Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease
In a high-risk, general population, RSVpreF vaccination conferred protection against RSV-related LRTD in the hospital and ED settings among US adults aged 60 years or older, the majority of whom were aged 75 years or older and had comorbidities. These data support use of this vaccine in older adults.
Authors
- Bradley K. Ackerson (ORCID: https://orcid.org/0000-0002-0816-7345)
- Michael Aragones
- Sabrina Welsh
- Sally F. Shaw (ORCID: https://orcid.org/0000-0002-6553-1772)
- Joseph A. Lewnard (ORCID: https://orcid.org/0000-0002-8505-8839)
- Michael P. Dutro
- Vennis Hong (ORCID: https://orcid.org/0000-0002-6060-8419)
- Sara Y. Tartof (ORCID: https://orcid.org/0000-0003-2336-8476)
- Guy M. Goodwin (ORCID: https://orcid.org/0000-0002-1426-2816)
- Negar Aliabadi (ORCID: https://orcid.org/0000-0002-9264-5089)
- Brigitte Spence (ORCID: https://orcid.org/0000-0003-2386-9967)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Banshri Kapadia
- Jeff Slezak (ORCID: https://orcid.org/0000-0002-6108-9198)
- Julie Stern (ORCID: https://orcid.org/0000-0002-0888-0810)
- Bradford D. Gessner (ORCID: https://orcid.org/0000-0002-6216-7194)
- Gregg S. Davis (ORCID: https://orcid.org/0000-0001-7684-0426)
- Luis Jódar (ORCID: https://orcid.org/0000-0003-1246-530X)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- Qing Liu (ORCID: https://orcid.org/0000-0003-2028-973X)
- B.L. Chia
- Elisa Gonzalez
- Robin Hubler
Institutions
- Kaiser Permanente (US)
- Pfizer (United States) (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.50832
- Citations
- 30
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 11.60
Funders
- Pfizer